Are you Dr. Greenbaum?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 31 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
University Of Washington Medical Ctr
Seattle, WA 98195Phone+1 206-598-4882
Summary
- Dr. Carla Greenbaum, MD is an endocrinologist in Seattle, Washington. She is currently licensed to practice medicine in Washington and Oregon. She is affiliated with UW Medicine/University of Washington Medical Center.
Education & Training
Swedish Medical Center/Cherry HillResidency, Family Medicine, 1981 - 1984
The Warren Alpert Medical School of Brown UniversityClass of 1981
Certifications & Licensure
OR State Medical License 1985 - Present
WA State Medical License 1982 - 2026- American Board of Family Medicine Family Medicine
Clinical Trials
- TrialNet Pathway to Prevention of T1D Start of enrollment: 2004 Feb 01
- Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus Start of enrollment: 2007 Feb 01
- Proleukin and Rapamune in Type 1 Diabetes Start of enrollment: 2007 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 444 citationsAn Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 DiabetesKevan C. Herold, Brian N. Bundy, S. Alice Long, Jeffrey A. Bluestone, Linda A. DiMeglio
The New England Journal of Medicine. 2019-06-09 - 48 citationsIL-2 therapy in type 1 diabetes: "Trials" and tribulations.S. Alice Long, Jane H. Buckner, Carla J. Greenbaum
Clinical Immunology. 2013-12-01 - 248 citationsRapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs β-Cell FunctionS. Alice Long, Mary Rieck, Srinath Sanda, Jennifer B. Bollyky, Peter L. Samuels
Diabetes. 2012-09-01
Press Mentions
Provention’s Tzield Can Delay Type 1 Diabetes. But Will It Reach All Patients?January 10th, 2023- Study: An Old Blood Pressure Pill May Help New Patients with Type 1 DiabetesMarch 23rd, 2022
- Seattle Covid Vaccine Study Participants Now Finding Out if They Got the Real DealJanuary 13th, 2021
- Join now to see all
Grant Support
- Northwest Clinical Center For Type 1 Diabetes - TrialnetNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2011
- Suppression Of T Cell Response To Islet Antigens By IV Insulin TherapyNational Center For Research Resources2005
- Natural History Of "Silent" DiabetesNational Center For Research Resources2000–2002
- Beta Cell REST To Prevent Type 1 DiabetesNational Center For Research Resources1996–2002
- DQB1*0602 Relatives--Mechanisms For Diabetes ProtectionNational Institute Of Allergy And Infectious Diseases2000–2001
- Secretion In Families Of PTS W/ Insulin Dependent DiabetesNational Center For Research Resources2000
- Natural History Of Silent DiabetesNational Center For Research Resources1998–2000
- Metabolic Characterization Of Subjects With Post Prandial DiabetesNational Center For Research Resources1998–2000
- DQB1*0602 Relatives--Mechanisms For Diabetes ProtectionNational Institute Of Allergy And Infectious Diseases1999
- Islet Cell Surface Antibodies - B-Cell FunctionNational Institute Of Diabetes And Digestive And Kidney Diseases1988
Professional Memberships
- Member
